Trading Alert - Relmada Therapeutics, Inc. (RLMD) Addresses Chronic Pain.
No ratings
Good Thursday morning, everybody. As promised, we've got an early delivery of today's newsletter to make sure you have plenty of time to take action with today's trading alert on our newest Featured Stock. In fact, as a bonus for you regular newsletter readers,
it's not even a Featured Stock at the site yet. We won't flip
that switch until after the close today, which means you have a few hours of knowing something other investors don't.
The usual caveats apply, of course. That is, understand that this is a speculative small cap, and as such, stops as well as limit orders are advised. Also, never invest more than you're willing to lose.
On the other hand, the usual upsides apply too - catching the right stock at the right time is like catching lightning in a bottle. And in today's case, we think this is very much a right-time, right-place situation. This biopharma company has been laying low for a while, and if history repeats itself (which it usually does), something big news-wise has been brewing and is about to surface... the classic catalyst for small cap biotech stocks.